相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of natural killer cell in gastrointestinal cancer: killer or helper
Feixue Wang et al.
ONCOGENE (2021)
Regulatory T cells promote glioma cell stemness through TGF-β-NF-κB-IL6-STAT3 signaling
Shasha Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Immune evasion by cancer stem cells
Hiroyuki Tsuchiya et al.
REGENERATIVE THERAPY (2021)
The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis
Gregory E. Idos et al.
SCIENTIFIC REPORTS (2020)
Targeting Natural Killer Cells for Tumor Immunotherapy
Cai Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis
Fatmah A. Mansour et al.
ONCOIMMUNOLOGY (2020)
Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer
Luis Alberto Solis-Castillo et al.
BREAST CANCER (2020)
Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
Rowa Y. Alhabbab
FRONTIERS IN GENETICS (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Rui Su et al.
CANCER CELL (2020)
The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer
Naoko Komura et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Tumor-Associated Macrophage Status in Cancer Treatment
Anna Maria Malfitano et al.
CANCERS (2020)
Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer
Noura N. Alraouji et al.
MOLECULAR CARCINOGENESIS (2020)
Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
Xu Yang† et al.
LANCET ONCOLOGY (2020)
Role of LLT1 and PCNA as Natural Killer Cell Immune Evasion Strategies of HCT 116 Cells
Joseph D. Malaer et al.
ANTICANCER RESEARCH (2020)
CD44, a marker of cancer stem cells, is positively correlated with PD-L1 expression and immune cells infiltration in lung adenocarcinoma
Chenyue Zhang et al.
CANCER CELL INTERNATIONAL (2020)
N6-methyladenosine (m6A)RNAmodification in cancer stem cells
Zhonghua Ma et al.
STEM CELLS (2020)
A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
Lori J. Goldstein et al.
BREAST CANCER RESEARCH (2020)
Induction of breast cancer stem cells by M1 macrophages through Lin-28B-let-7-HMGA2 axis
Liang Guo et al.
CANCER LETTERS (2019)
Cognate Nonlytic Interactions between CD8+ T Cells and Breast Cancer Cells Induce Cancer Stem Cell-like Properties
Roland G. Stein et al.
CANCER RESEARCH (2019)
Preclinical Evaluation of Chimeric Antigen Receptor-Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer
Bing-Lan Zhang et al.
HUMAN GENE THERAPY (2019)
IL-10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF-κB/Notch1 pathway in non-small cell lung cancer
Li Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways
Li Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti-PD-1 in melanoma
Laurene S. Cheung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The CXCL8-CXCR1/2 Axis as a Therapeutic Target in Breast Cancer Stem-Like Cells
Pier Adelchi Ruffini
FRONTIERS IN ONCOLOGY (2019)
Induction of tolerogenic dendritic cells by activated TGF-/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells
Ming Zhong et al.
BMC CANCER (2019)
PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways
Fang Wei et al.
CANCER LETTERS (2019)
Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells
Yuxuan Miao et al.
CELL (2019)
Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation
Lisha Ai et al.
MOLECULAR CANCER (2019)
A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma
Ye-Bin Pang et al.
STEM CELLS INTERNATIONAL (2019)
The Evolving Landscape of Cancer Stem Cells and Ways to Overcome Cancer Heterogeneity
Hiroaki Taniguchi et al.
CANCERS (2019)
Gastric Cancer Stem Cells Effect on Th17/Treg Balance; A Bench to Beside Perspective
Alaleh Rezalotfi et al.
FRONTIERS IN ONCOLOGY (2019)
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
Li-Chuan Chan et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira A. Barkal et al.
NATURE (2019)
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta et al.
CANCER DISCOVERY (2019)
Disruption of the NF-κB/IL-8 Signaling Axis by Sulconazole Inhibits Human Breast Cancer Stem Cell Formation
Hack Sun Choi et al.
CELLS (2019)
T Regulatory Cells and Priming the Suppressive Tumor Microenvironment
Christina M. Paluskievicz et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy
Shilpa Ravindran et al.
CANCER MICROENVIRONMENT (2019)
Tumor-associated macrophages: an accomplice in solid tumor progression
Yibing Chen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Deciphering the Dynamics of Epithelial-Mesenchymal Transition and Cancer Stem Cells in Tumor Progression
Federico Bocci et al.
CURRENT STEM CELL REPORTS (2019)
Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment
Yelei Guo et al.
PROTEIN & CELL (2018)
NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines
Leticia Huergo-Zapico et al.
CANCER RESEARCH (2018)
When worlds collide: Th17 and Treg cells in cancer and autoimmunity
Hannah M. Knochelmann et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification
Yutaka Kurebayashi et al.
HEPATOLOGY (2018)
Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints
Tao Shi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-specific immunosurveillance in lung cancer
Peter J. Chockley et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
Christopher C. Kloss et al.
MOLECULAR THERAPY (2018)
Immune consequences of anti-angiogenic therapy in renal cell carcinoma
Klaudia K. Brodaczewska et al.
Wspolczesna Onkologia-Contemporary Oncology (2018)
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
Jung-Mao Hsu et al.
NATURE COMMUNICATIONS (2018)
Neurotensin/IL-8 pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of Tumor-Associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells
Pei Xiao et al.
ONCOIMMUNOLOGY (2018)
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
Yao Wang et al.
ONCOIMMUNOLOGY (2018)
Cancer Stem Cell Vaccination With PD-L1 and CTLA-4 Blockades Enhances the Eradication of Melanoma Stem Cells in a Mouse Tumor Model
Fang Zheng et al.
JOURNAL OF IMMUNOTHERAPY (2018)
Cancer stem cells as targets for DC-based immunotherapy of colorectal cancer
Magdalena Szarynska et al.
SCIENTIFIC REPORTS (2018)
Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis
Lisha Ai et al.
BMC CANCER (2018)
ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer
Sushil Kumar et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Tim-3 expression and its role in hepatocellular carcinoma
Feifei Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer
Dong Wang et al.
CELL DEATH AND DIFFERENTIATION (2018)
Targeting Tumor-Associated Macrophages as a Potential Strategy to Enhance the Response to Immune Checkpoint Inhibitors
Luca Cassetta et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
PD-1 blockade modulates chimeric antigen receptor (CAR)-modified T cells: refueling the CAR
Elise A. Chong et al.
BLOOD (2017)
Hide-and-seek: the interplay between cancer stem cells and the immune system
Mohammad Sultan et al.
CARCINOGENESIS (2017)
Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer
Min Xu et al.
EXPERIMENTAL CELL RESEARCH (2017)
PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
Sheema Almozyan et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
Masaru Katoh
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Is CD47 an innate immune checkpoint for tumor evasion?
Xiaojuan Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma
Andras Heczey et al.
MOLECULAR THERAPY (2017)
Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40
Aaron E. Foster et al.
MOLECULAR THERAPY (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma
David Kung-Chun Chiu et al.
NATURE COMMUNICATIONS (2017)
Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade
Maria Ouzounova et al.
NATURE COMMUNICATIONS (2017)
Tumor-Derived Mesenchymal Stem Cells Use Distinct Mechanisms to Block the Activity of Natural Killer Cell Subsets
Sabine Galland et al.
CELL REPORTS (2017)
Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development
Federica Papaccio et al.
STEM CELLS TRANSLATIONAL MEDICINE (2017)
Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer
Anne F. Schott et al.
CLINICAL CANCER RESEARCH (2017)
Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles
Lucas Treps et al.
JOURNAL OF EXTRACELLULAR VESICLES (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies
C. Raggi et al.
ONCOGENE (2016)
Immunological and Clinical Impact of Cancer Stem Cells in Vulvar Cancer: Role of CD133/CD24/ABCG2-Expressing Cells
Chiara Napoletano et al.
ANTICANCER RESEARCH (2016)
Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease
John Koreth et al.
BLOOD (2016)
Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling
Dongjun Peng et al.
CANCER RESEARCH (2016)
Human cancer cells with stem cell-like phenotype exhibit enhanced sensitivity to the cytotoxicity of IL-2 and IL-15 activated natural killer cells
Tao Yin et al.
CELLULAR IMMUNOLOGY (2016)
Cancer stem cells and tumor immunoediting: putting two and two together
Alka Bhatia et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma: Relationship With Clinical and Pathological Features
Julien Calderaro et al.
HEPATOLOGY (2016)
Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies
Bruno Sainz et al.
MEDIATORS OF INFLAMMATION (2016)
Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
Erin A. Marshall et al.
MOLECULAR CANCER (2016)
Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation
Thomas Welte et al.
NATURE CELL BIOLOGY (2016)
A New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem Cells
Rossana Tallerico et al.
FRONTIERS IN IMMUNOLOGY (2016)
The NF-κB Pathway and Cancer Stem Cells
Amanda L. Rinkenbaugh et al.
CELLS (2016)
Expression of Sox2 in breast cancer cells promotes the recruitment of M2 macrophages to tumor microenvironment
Wenjun Mou et al.
CANCER LETTERS (2015)
Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell Activation
Elena Jachetti et al.
CANCER RESEARCH (2015)
Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice
Dingzhi Wang et al.
GASTROENTEROLOGY (2015)
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype
Erik Ames et al.
JOURNAL OF IMMUNOLOGY (2015)
TGF-β and EGF induced HLA-I downregulation is associated with epithelial-mesenchymal transition (EMT) through upregulation of snail in prostate cancer cells
Xiao-Hui Chen et al.
MOLECULAR IMMUNOLOGY (2015)
Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Wenchao Zhou et al.
NATURE CELL BIOLOGY (2015)
Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches
Qin Pan et al.
STEM CELLS (2015)
Revving up natural killer cells and cytokine-induced killer cells against hematological malignancies
Gianfranco Pittari et al.
FRONTIERS IN IMMUNOLOGY (2015)
Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells
Erik Ames et al.
ONCOIMMUNOLOGY (2015)
Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer
T. Xiang et al.
ONCOGENE (2015)
The PD-1/B7-H1 Pathway Modulates the Natural Killer Cells versus Mouse Glioma Stem Cells
Bo Yuan Huang et al.
PLOS ONE (2015)
Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57
Xuekai Zhu et al.
ONCOTARGET (2015)
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study
M. V. Dieci et al.
ANNALS OF ONCOLOGY (2014)
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer
Roheena Z. Panni et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells
Bin Wang et al.
CANCER RESEARCH (2014)
Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8
Weiyuan Fang et al.
CARCINOGENESIS (2014)
Hypothesis: Tim-3/Galectin-9, A New Pathway for Leukemia Stem Cells Survival by Promoting Expansion of Myeloid-Derived Suppressor Cells and Differentiating into Tumor-Associated Macrophages
Lei Gao et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
Shanshan Wan et al.
GASTROENTEROLOGY (2014)
Blockade of CD47-Mediated Cathepsin S/Protease-Activated Receptor 2 Signaling Provides a Therapeutic Target for Hepatocellular Carcinoma
Terence Kin-Wah Lee et al.
HEPATOLOGY (2014)
Tumor-Derived α-Fetoprotein Impairs the Differentiation and T Cell Stimulatory Activity of Human Dendritic Cells
Angela D. Pardee et al.
JOURNAL OF IMMUNOLOGY (2014)
A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages
Haihui Lu et al.
NATURE CELL BIOLOGY (2014)
A New Strategy Using ALDHhigh-CD8+T Cells to Inhibit Tumorigenesis
Huiyan Luo et al.
PLOS ONE (2014)
Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice
D. Chandra et al.
BRITISH JOURNAL OF CANCER (2013)
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
Jonathan B. Mitchem et al.
CANCER RESEARCH (2013)
Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2
Tracy X. Cui et al.
IMMUNITY (2013)
Epithelial-Mesenchymal Transition Induces an Antitumor Immune Response Mediated by NKG2D Receptor
Alejandro Lopez-Soto et al.
JOURNAL OF IMMUNOLOGY (2013)
Human NK Cells Selective Targeting of Colon Cancer-Initiating Cells: A Role for Natural Cytotoxicity Receptors and MHC Class I Molecules
Rossana Tallerico et al.
JOURNAL OF IMMUNOLOGY (2013)
Tumor-Associated Macrophages Regulate Murine Breast Cancer Stem Cells Through a Novel Paracrine EGFR/Stat3/Sox-2 Signaling Pathway
Jian Yang et al.
STEM CELLS (2013)
Dendritic Cells in the Cancer Microenvironment
Yang Ma et al.
JOURNAL OF CANCER (2013)
Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity
Miaorong She et al.
CANCER LETTERS (2012)
CD44s Regulates the TGF-β-Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
Kosuke Mima et al.
CANCER RESEARCH (2012)
IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction - A comparative study of human clinical-applicable DC
Martine A. Boks et al.
CLINICAL IMMUNOLOGY (2012)
Interaction between regulatory T cells and cancer stem cells
Xiaozhou Yu et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Blockade of interleukin-6 receptor suppresses the proliferation of H460 lung cancer stem cells
Hee Yi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation
Yijing Li et al.
MOLECULAR CANCER (2012)
TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
Xin Gao et al.
PLOS ONE (2012)
MFG-E8 Released by Apoptotic Endothelial Cells Triggers Anti-Inflammatory Macrophage Reprogramming
Marie-Joelle Brissette et al.
PLOS ONE (2012)
Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
Wolf Herman Fridman et al.
CANCER RESEARCH (2011)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2011)
Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer
James Krempski et al.
JOURNAL OF IMMUNOLOGY (2011)
Foxp3(+)IL-17(+) T cells promote development of cancer-initiating cells in colorectal cancer
Shaobo Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Glioma-initiating cells: A predominant role in microglia/macrophages tropism to glioma
Liang Yi et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Oncolytic Herpes Simplex Virus 1 Encoding 15-Prostaglandin Dehydrogenase Mitigates Immune Suppression and Reduces Ectopic Primary and Metastatic Breast Cancer in Mice
Jason D. Walker et al.
JOURNAL OF VIROLOGY (2011)
A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours
Benjamin Beck et al.
NATURE (2011)
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Andrea Facciabene et al.
NATURE (2011)
Hypoxia Potentiates Glioma-Mediated Immunosuppression
Jun Wei et al.
PLOS ONE (2011)
Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells
Masahisa Jinushi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
Suzanne Ostrand-Rosenberg
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Myeloid-Derived Suppressor Cells in Human Cancer
Srinivas Nagaraj et al.
CANCER JOURNAL (2010)
Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
Tobias Schatton et al.
CANCER RESEARCH (2010)
Knockout of HIF-1α in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses
Christian Werno et al.
CARCINOGENESIS (2010)
TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
Yoshikane Kikushige et al.
CELL STEM CELL (2010)
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Christophe Ginestier et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Up for Mischief? IL-17/Th17 in the tumour microenvironment
E. Maniati et al.
ONCOGENE (2010)
Increased Lysis of Stem Cells but Not Their Differentiated Cells by Natural Killer Cells; De-Differentiation or Reprogramming Activates NK Cells
Han-Ching Tseng et al.
PLOS ONE (2010)
cd277 is a Negative Co-stimulatory Molecule Universally Expressed by Ovarian Cancer Microenvironmental Cells
Juan R. Cubillos-Ruiz et al.
ONCOTARGET (2010)
FOXP3+ regulatory T cells in the human immune system
Shimon Sakaguchi et al.
NATURE REVIEWS IMMUNOLOGY (2010)
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
Dimitrios Iliopoulos et al.
CELL (2009)
EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
Taro Yamashita et al.
GASTROENTEROLOGY (2009)
Natural killer cells kill human melanoma cells with characteristics of cancer stem cells
Gabriella Pietra et al.
INTERNATIONAL IMMUNOLOGY (2009)
NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
Roberta Castriconi et al.
JOURNAL OF IMMUNOLOGY (2009)
Mesenchymal cells recruit and regulate T regulatory cells
Mauro Di Lanni et al.
EXPERIMENTAL HEMATOLOGY (2008)
New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation
Lai Wei et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4
Matilde Todaro et al.
CELL STEM CELL (2007)
TGFβ-dependent gene expression profile during maturation of dendritic cells
O. Fainaru et al.
GENES AND IMMUNITY (2007)
Molecular definition of breast tumor heterogeneity
Michail Shipitsin et al.
CANCER CELL (2007)
Distinct role of macrophages in different tumor microenvironments
CE Lewis et al.
CANCER RESEARCH (2006)
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2004)
Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway (vol 100, pg 4281, 2003)
H Ryu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
